Graft Versus Host Disease
9 drugs2,809 FAERS reportsMedDRA PT
GET
/api/v1/reaction/graft-versus-host-diseaseReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Graft Versus Host Disease (9)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Busulfan1,0525.8%
- 2Ziftomenib15.3%
- 3Treosulfan983.9%
- 4Thiotepa3113.4%
- 5Fludarabine1,2243.2%
- 6Methoxsalen202.7%
- 7Defibrotide792.2%
- 8Axatilimab21.8%
- 9Mogamulizumab221.7%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Acute Graft Versus Host Disease6 shared · 0.55
- Chronic Graft Versus Host Disease4 shared · 0.44
- Acute Graft Versus Host Disease In Skin4 shared · 0.40
- Cytomegalovirus Infection Reactivation4 shared · 0.24
- Graft Versus Host Disease In Skin2 shared · 0.20
- Human Herpesvirus 6 Infection2 shared · 0.20
- Acute Graft Versus Host Disease In Intestine2 shared · 0.18
- Venoocclusive Liver Disease3 shared · 0.18
- Cystitis Haemorrhagic2 shared · 0.17
- Venoocclusive Disease2 shared · 0.17
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.